Medication info
DuoM Tablet 40/5 mg

DuoM Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double-coated tablet in white and light blue
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201904302 · Approved 2019.06.21 · Insurance code 641502830

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this drug’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
Child dose
○ Children: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
McNulty Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used for the treatment of essential hypertension in patients who have difficulty controlling blood pressure with either telmisartan or amlodipine monotherapy.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this drug’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.

Child dose

○ Children: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication may pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or those who may become pregnant. It should not be administered to individuals allergic to the active ingredients or related compounds, patients with severe liver impairment, severe hypotension, significantly compromised cardiac function, or unstable heart failure following acute myocardial infarction. Patients with primary aldosteronism, certain heart valve diseases, liver disorders, gastrointestinal diseases, renal vascular hypertension, those on dialysis, and the elderly require special caution when using this medication. Common side effects include dizziness and peripheral edema, while serious side effects such as syncope have been reported rarely. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with a safer treatment. Hypotension may occur, so patients with dehydration or low salt levels should improve their condition before taking the medication and closely monitor their blood pressure. This medication can increase serum potassium levels, so patients with impaired renal function or heart failure should have their potassium levels regularly checked through blood tests. It is important for patients with impaired renal function to periodically monitor their kidney function and serum electrolyte levels while on this medication. Patients with heart disease should be cautious, as there may be an increased risk of angina or myocardial infarction after taking this medication. It is not recommended for breastfeeding women, and they should avoid taking it if they are nursing. This medication can interact with other drugs, so patients should inform their healthcare provider of any other medications they are taking, especially potassium supplements or certain diuretics. Drowsiness or dizziness may occur while on this medication, so caution is advised when driving or operating dangerous machinery. In cases of overdose, symptoms may include hypotension, dizziness, and decreased heart function, and immediate medical attention is required. This medication is not recommended for children due to the lack of established safety and efficacy, and elderly patients should start at a lower dose and gradually increase it. Store this medication out of the reach of children and in a sealed condition to maintain product quality.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphous erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius for efficacy.

Appearance and packaging

Appearance

Biconvex oval double-coated tablet in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.